JenaValve
CA - IrvineMedical Devices
Focus: JenaValve is a publicly-listed cardiovascular medical device company focused on transcatheter aortic valve replacement (TAVR) systems for aortic stenosis and regurgitation. The company operates from Irvine, CA with a specialized manufacturing footprint.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
10
Should You Work at JenaValve?
AI assessmentStrong fit for manufacturing engineers, QA specialists, and tissue-processing experts seeking early-stage commercial growth in a FDA-approved device; less appealing for generalists or those requiring large-scale career infrastructure.
Why Work Here
- Recent FDA approval (March 2026) for aortic regurgitation represents a major commercial inflection point and expansion into an underserved patient population.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Transcatheter Aortic Valve Replacement
Aortic RegurgitationClinical Trials (1)
NCT06608823ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
N/AHelp build intelligence for JenaValve
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.